Riskpilot← Back to searchSign inGet full accessNaprapat C Gransten AB
ABActiveOrg 5568239981Björngårdsgatan 4Physiotherapy activities · NACE 8695Est. 20101-4 employees
Revenue 2024
SEK 525K
+1% vs 2023
EBITDA margin
-28.1%
-324% vs 2023
Equity ratio
43.5%
Financial strength
Net profit 2024
SEK -158K
-241% vs 2023
| Revenue | SEK 525K | +1% |
| EBITDA | SEK -147K | -324% |
| Net profit | SEK -158K | -241% |
| Total assets | SEK 62K | -54% |
| Equity | SEK 27K | -70% |
| Employees | — | — |
Legal name
Naprapat C Gransten AB
Org number
5568239981
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
5 november 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva naprapatverksamhet, utbildning konsultationer inom ämnet hälsa-kost-träning, försäljning av tillbehör samt därmed förenlig verksamhet.
Address
Björngårdsgatan 4
Phone
+46707496333
Email
cecilia@dalarogym.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 728 | 543 | 508 | 520 | 525 |
| Staff expenses | — | — | — | −203 | −385 |
| EBITDA | 43 | 161 | −93 | −35 | −147 |
| Depreciation & amort. | −0 | −12 | −12 | −12 | −12 |
| EBIT | 43 | 149 | −105 | −47 | −159 |
| Net financials | — | — | — | 0 | 0 |
| Profit before tax | 38 | 110 | −60 | −46 | −159 |
| Tax | −4 | −23 | −0 | — | 0 |
| Net profit | 34 | 87 | −60 | −46 | −158 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 89 | 219 | 160 | 134 | 62 |
| Equity | 70 | 157 | 97 | 90 | 27 |
| Long-term debt | 0 | 0 | 0 | — | — |
| Short-term debt | 14 | 17 | 63 | 44 | 35 |
| Total debt | 14 | 17 | 63 | 44 | 35 |
EBITDA margin
-28.1%
This company
15.8%
Market median
-278% vs market
20202024
Equity ratio
43.5%
This company
38.2%
Market median
+14% vs market
20202024
Return on equity
-588.1%
This company
18.4%
Market median
-3296% vs market
20202024
Net profit margin
-30.2%
This company
8.1%
Market median
-473% vs market
20202024
Asset turnover
8.49×
This company
1.12×
Market median
+658% vs market
20202024
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Naprapat C Gransten AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ludwig Tor Jörgensborg | Deputy Board Member | 0 companies |
| Lennart Mikael Gransten | Deputy Board Member | 0 companies |
| Cecilia Mary Gransten | Board of Directors | 0 companies |